Plato Investment Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Plato Investment Management's AMGN Position: Q2 2026 in Review
Plato Investment Management increased its Amgen (AMGN) stake by 2.7% in Q2 2026, buying an estimated $205K and bringing the position to 22,412 shares worth $8.07M. The position accounts for 0.46% of the portfolio, ranked #42.
Plato Investment Management first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Plato Investment Management held 22,412 shares of Amgen worth $8.07M as of Q2 2026.
- Plato Investment Management bought 599 Amgen shares in Q2 2026, an estimated $205K.
- Amgen made up 0.46% of Plato Investment Management's portfolio in Q2 2026, its #42 holding.
- Plato Investment Management first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Plato Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.